Therapeutic Drug Monitoring for Evaluation of the Efficacy and Safety of Vancomycin in Patients with Orthopaedic Infections

QR Code

Therapeutic Drug Monitoring for Evaluation of the Efficacy and Safety of Vancomycin in Patients with Orthopaedic Infections

Vancomycin is a drug of choice for the infections caused by methicillin-resistant strains of staphylococci. Its use requires individualised dosing and renal function monitoring.The aim of the study was to evaluate, using therapeutic drug monitoring (TDM), the frequency of reaching target trough seru...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. S. Tufanova, A. R. Kasimova, S. A. Bozhkova
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-07-01
Series:	Безопасность и риск фармакотерапии
Subjects:	vancomycin nephrotoxicity therapeutic drug monitoring trough serum concentration drug-induced renal disorder
Online Access:	https://www.risksafety.ru/jour/article/view/276
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Unexpected falsely high vancomycin concentrations in a patient with endocarditis during routine therapeutic drug monitoring
by: Laura Galán-Caballero, et al.
Published: (2025-06-01)

Experience of Using Therapeutic Drug Monitoring to Control the Safety of Vancomycin in Intensive Care Unit Patients with Sepsis
by: A. B. Prokofiev, et al.
Published: (2022-07-01)

Predictors of caspofungin exposure-response relationship: a retrospective cohort study on therapeutic drug monitoring parameters
by: Mingwei Meng, et al.
Published: (2025-07-01)

The Effect of Dapagliflozin, a Sodium–Glucose Co-Transporter 2 Inhibitor, on Vancomycin-Induced Nephrotoxicity in Rats
by: Seyhmus Tan, et al.
Published: (2025-06-01)

Optimization of therapeutic drug monitoring of vancomycin in newborns using “Dried Blood Spot” method
by: V. I. Petrov, et al.
Published: (2024-01-01)

Impact of Recovery from Febrile Neutropenia on Intra-Individual Variability in Vancomycin Pharmacokinetics in Pediatric Patients
by: Yukie Takumi, et al.
Published: (2025-06-01)

A real-world study of the optimal cut-off value for vancomycin trough concentration associated with outcomes in children infected with drug-resistant Gram-positive bacteria
by: Yinghui Yan, et al.
Published: (2025-07-01)

Determination of Serum/Plasma Concentrations of Psychotropic Drugs in Therapeutic Drug Monitoring
by: I. I. Miroshnichenko, et al.
Published: (2021-09-01)

Faecal microbiota transplantation to decolonize vancomycin-resistant Enterococcus: A pilot study to evaluate safety and clinical outcome
by: Shu-Min Lin, et al.
Published: (2025-06-01)

Is It Possible to Optimize the Elaboration and Preservation of a Vancomycin Catheter Lock Solution?
by: Marta Díaz-Navarro, et al.
Published: (2025-06-01)

Therapeutic Drug Monitoring of Antibiotics Is Needed in the Treatment of Sepsis
by: G. P. Plotnikov, et al.
Published: (2022-12-01)

OPTIMIZATION OF THE HEART RATE CONTROL IN ATRIAL FIBRILLATION BY MONITORING OF THE DIGOXIN CONCENTRATION IN ELDERLY PATIENTS
by: S. F. Zadvorev, et al.
Published: (2018-07-01)

Determination of the Effectiveness of Antibiotic Therapy by Conducting Therapeutic Drug Monitoring
by: A. M. Kazanova, et al.
Published: (2020-06-01)

THE ROLE OF THE THERAPEUTIC DRUG MONITORING WHEN USING ANTIEPILEPTIC DRUGS
by: A. V. Yakunina, et al.
Published: (2016-12-01)

RESULTS OF THERAPEUTIC DRUG MONITORING COMBINATION THERAPY OF ANTICONVULSANTS IN CLINICAL PRACTICS
by: M. V. Leonova, et al.
Published: (2016-05-01)

THERAPEUTIC DRUG MONITORING OF ANTICONVULSANTS IN CLINICAL PRACTICS
by: Yu. B. Belousov, et al.
Published: (2016-05-01)

THERAPEUTIC DRUG MONITORING OF ANTICONVULSANTS IN CHILDREN IN CLINICAL PRACTICE
by: M. V. Leonova, et al.
Published: (2017-05-01)

Guideline for the use of therapeutic drug monitoring of antipsychotics to individualize the selection of therapy in the treatment of exacerbation of schizophrenia
by: S. S. Potanin, et al.
Published: (2023-12-01)

Therapeutic drug monitoring of methotrexate and its metabolites in the red blood cells and mononuclear cells of patients with rheumatoid arthritis
by: G. I. Gridneva, et al.
Published: (2020-11-01)

Determination of Vancomycin B and Vancomycin Impurities by Liquid Chromatography
by: S. I. Kuleshova, et al.
Published: (2021-12-01)

Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid
by: M. V. Zhuravleva, et al.
Published: (2023-12-01)

Pharmacokinetic analysis of meropenem therapeutic drug monitoring data (TDM) in critically ill adult patients
by: I. B. Bondareva, et al.
Published: (2022-03-01)

THERAPEUTIC DRUG MONITORING OF LAMOTRIGINE: DEVELOPMENT OF PHARMACOKINETIC APPROACHES AIMING AT THE INDIVIDUAL-BASED ANTICONVULSIVE PHARMACOTHERAPY
by: D. A. Abaimov, et al.
Published: (2016-05-01)

EFFICACY AND SAFETY OF ANTIEPILEPTIC DRUGS DURING PREGNANCY: PHARMACOGENETIC ASPECTS
by: E. A. Sоkоvа, et al.
Published: (2018-06-01)

Optimization of Isavuconazole Dosing in Patients with Invasive Fungal Infections Through Therapeutic Drug Monitoring: Real-World Clinical Practice Experience
by: Diego Peña-Lorenzo, et al.
Published: (2025-06-01)

MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. F. Zadvorev, et al.
Published: (2018-05-01)

The Use of Therapeutic Drug Monitoring to Personalize Once-daily Intravenous Busulfan in Thai Pediatric Patients Underwent Hematopoietic Stem Cell Transplantation
by: Cholada Ratanatharathorn, et al.
Published: (2025-08-01)

Navigating Therapeutic drug monitoring of Isavuconazole in Invasive Mold Infection on Extracorporeal membrane oxygenation - A Case Report
by: Blain Thayer, et al.
Published: (2025-07-01)

Formulation and Characterization of Bone-Targeting Vancomycin-Loaded Liposomes
by: Basel Karzoun, et al.
Published: (2025-06-01)

Cost-effectiveness of therapeutic drug monitoring of perampanel for pediatrics with epilepsy: real-world data
by: Yani Hu, et al.
Published: (2025-06-01)

Results of Investigation of MRSA Susceptibility to Vancomycin in Clinical Units of Large Multifunctional Hospital and Recommendations on Optimization of Antibacterial Therapy of Staphylococcal Infection
by: V. A. Verikovsky, et al.
Published: (2020-05-01)

The Effects of Shock Vancomycin Concentrations on the Formation of Heteroresistance in Staphylococcus aureus
by: V. V. Gostev, et al.
Published: (2020-12-01)

MODERN TECHNOLOGIES IN THERAPEUTIC DRUG MONITORING (REVIEW)
by: D. A. Abaimov, et al.
Published: (2016-05-01)

Correlation of Neutrophil-Lymphocyte Ratio and Critical Illness in Adults on Vancomycin: A Cross-Sectional Study
by: Alfhili MA, et al.
Published: (2025-07-01)

Research progress on the transmission and control of vancomycin-resistant Enterococcus in the environment: a review
by: Hui LI, et al.
Published: (2025-06-01)

Monitoring Plasma Concentrations of Intravenously Administered Fosfomycin to Prevent Drug-Related Adverse Events: A Retrospective Observational Study
by: Kathrin Marx, et al.
Published: (2025-05-01)

Dasatinib Dose Optimization Based on Therapeutic Drug Monitoring in Patients with Chronic-Phase Chronic Myeloid Leukemia
by: Cheng F, et al.
Published: (2025-05-01)

NEW METHODS OF OPTIMIZATION OF EPILEPSY PHARMACOTHERAPY: USE OF BAYESIAN PHARMACOKINETIC MODELING
by: Z. А. Suslina, et al.
Published: (2016-09-01)

ADAPTATION OF “DRIED BLOOD DROP” METHOD FOR THERAPEUTIC DRUG MONITORING
by: V. I. Petrov, et al.
Published: (2022-10-01)

Estimation of MRSA Susceptibility to Oxacillin, Cefoxitine, Vancomycin and Daptomyci
by: V. V. Gostev, et al.
Published: (2020-05-01)